Primary procedure was performed by dr.(b)(6) at (b)(6) medical center, in (b)(6) in (b)(6), on (b)(6) 2017.Patient was implanted with an afx2 bifurcated stent, a afx vela suprarenal, a afx limb stent graft, and an ovation ix extender.On (b)(6) 2018, it was discovered that the patient had a indeterminate endoleak (possible type 3a) between the main body limb and left distal extension.On (b)(6) 2018, the left distal extension was relined with another afx limb stent graft of the same size.Completion angio showed no further evidence of a type 3a endoleak, but did reveal a persistent type 2 endoleak.Patient was reported to be in a stable condition post op.No additional event or patient information is available.
|
An evaluation of the reported event could not be completed due to a lack of receipt of relevant medical records and/or imaging.Requests were made and denied response were received.As such, event determination, off label conditions, related patient harms and patient disposition could not be independently assessed.The review of manufacturing lot confirmed all devices met specifications prior to release.No additional investigations of this reported complaint are planned.Endologix will continue to monitor this complaint and similar complaints in the event further investigation is needed.
|